Diagnosis of Heart Failure in Chronic Obstructive Pulmonary Disease Using the Lung Ultrasound
1 other identifier
observational
350
1 country
1
Brief Summary
Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the lung ultrasound could be useful in this issue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 9, 2022
CompletedFirst Posted
Study publicly available on registry
April 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedJuly 7, 2026
August 1, 2022
1.2 years
March 9, 2022
July 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
LUS in COPD patients whith pulmonory echography
LUS measured whith pulmonory echography by the number of lines A and B.
1day
the accuracy of LUS in the diagnosis of heart failure in COPD patients
the accuracy of LUS in the diagnosis of heart failure in patients with COPD measured by area under the roc curve
1day
Study Arms (2)
HF-group
patients with AECOPD and acute heart failure
non HF-group
patients with AECOPD without acute heart failure
Interventions
Eligibility Criteria
patients with history of COPD admitted to the emergency departmet for dyspnea
You may qualify if:
- patients with history of COPD admitted to the emergency department for dyspnea non traumatic dyspnea
You may not qualify if:
- instable hemodynamic or neurological status non consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Departement
Monastir, 5000, Tunisia
Related Publications (1)
Lajili F, Toumia M, Sekma A, Bel Haj Ali K, Sassi S, Zorgati A, Yaakoubi H, Youssef R, Grissa MH, Beltaief K, Mezgar Z, Khrouf M, Chamtouri I, Bouida W, Boubaker H, Msolli MA, Dridi Z, Boukef R, Nouira S. Value of Lung Ultrasound Sonography B-Lines Quantification as a Marker of Heart Failure in COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2024 Aug 1;19:1767-1774. doi: 10.2147/COPD.S447819. eCollection 2024.
PMID: 39108664DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nouira semir Nouira semir, professor
Principal Investigator university
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 9, 2022
First Posted
April 28, 2022
Study Start
March 1, 2022
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
July 7, 2026
Record last verified: 2022-08